Near 100 percent mammagraphy recall compliance costs less than a quarter per patient

May 04, 2006

The hidden costs of achieving a 99.5% mammography recall compliance rate is 16 cents per screening patient, according to a recent study administered by the radiology department at the University of Michigan in Ann Arbor, MI.

From 2002-2004, 4,025 of 30,286 screening patients were recalled for another mammogram. Out of 4,005 patients, 3,977 returned for a diagnostic study after an average of two phone calls, which averaged 3.65 minutes of total clerical time and cost $1.03 per case (clerical salary + benefits averaged $17 per hour). Forty-eight out of 4,025 initially noncompliant patients received an average of six phone calls, (totaling 4.7 minutes) plus clerical costs for this group of $2.27 with the additional cost of $7.50 for a registered letter, totaling $9.77 per case. Twenty-eight of this group returned for additional screening and the study discovered one of these initially noncompliant patients went on to biopsy revealing a breast cancer.

The total cost for this program was $4,581.84 or $0.16 per screening patient.

"Departments are continually trying to trim waste and eliminate overhead costs in this era of spiraling health costs," said Caroline Blane, MD, lead researcher of the study and radiology department associate chair for clinical services. "We use clerical time to track down noncompliant patients to schedule them and the question arose as to how high was the cost of this clerical time and how much benefit was derived."

"The surprising part was how little it added to the cost of each screening study, 16 cents, to achieve this compliance. As noted in the study, one of the initially noncompliant patients did have an early curable breast cancer which was appropriately treated because we have this safety net and spent the time and so little money getting her to return for a diagnostic mammogram," said Dr. Blane. "If for every 30,000 screening mammograms we pick up one early breast cancer, I believe a delay in diagnosis of this one breast cancer would have cost considerably more in the long run than the 16 cents per screening mammogram. Not only are we providing a patient service with improved patient outcome but we are probably also saving health care dollars," added Dr. Blane.

The full results of this study will be presented on Thursday, May 4, 2006 during the American Roentgen Ray Society Annual Meeting in Vancouver, BC.
-end-
About ARRS
The American Roentgen Ray Society (ARRS) was founded in 1900 and is the oldest radiology society in the United States. Radiologists from all over the world attend the ARRS Annual Meeting to take part in instructional courses, scientific paper presentations, symposiums, new issues forums and scientific and commercial exhibits related to the field of radiology. The ARRS is named after Wilhelm Röentgen, who discovered the x-ray in 1895.

American College of Radiology

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.